The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
and so there's a peptide pt41 that falls into this category of activating the melanocortin system and pt-141 is also known as the prescription drug VII pt41 or VII is FDA approved for the treatment of premenopause fusal hypoactive sexual desire so this is FDA approved for the treatment of women that have suppressed libido however men also will take VII um for hypoactive uh sexual desire um this is obviously prescribed off label um by physicians
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
keep in mind as with the other peptides in this pathway VII will stimulate pigmentation
it's a cyclic seven amino acid melanocortin receptor Agonist with a high affinity for What's called the type formulanacortin receptors and it's an analog of msh which is melanocyte stimulating hormone and what it does in in the end is it acts in brain Pathways that stimulate dopaminergic Pathways